---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-024955"
form_type: "8-K"
ticker: "LMAT"
cik: "0001158895"
company_name: "LEMAITRE VASCULAR INC"
filed_at: "2022-10-27T23:59:59+00:00"
generated_at: "2026-06-22T23:38:33.302111+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LeMaitre Q3 sales $39M (+2%), EPS $0.25 (-17%); declares $0.125 dividend

## Summary
- Q3 sales $39.0M (+2% reported, +7% organic YoY); EPS $0.25 diluted, down 17%.
- Q3 operating income $6.2M, -32%; net income $5.5M, -16%.
- Full-year 2022 guidance: sales $160.5M-$162.9M; EPS $0.91-$0.97 (ex-special $1.02-$1.08).
- Quarterly dividend of $0.125/share, payable Dec 1, 2022 to holders of record Nov 17.
- Appointed Martha Shadan as independent director, effective Sept 21, 2022.

## SEC filing metadata
- accession: 0001437749-22-024955
- form_type: 8-K
- ticker: LMAT
- cik: 0001158895
- company_name: LEMAITRE VASCULAR INC
- filed_at: 2022-10-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158895/000143774922024955/0001437749-22-024955-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158895/000143774922024955/lmat20221027_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-024955
- JSON: https://secwatch.observer/filing/0001437749-22-024955.json
- Plain text: https://secwatch.observer/filing/0001437749-22-024955.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.